Hair loss trial pulled before it even started

NCT ID NCT02849470

First seen Jun 26, 2026 · Last updated Jun 26, 2026

Summary

This trial aimed to test a combination of platelet-rich plasma and stem cells from fat tissue for treating male and female pattern hair loss. It was designed to compare different mixtures injected into the scalp. However, the study was withdrawn before enrolling any participants, so no results are available.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

Platelet-rich plasma and fat-derived stem cells

What this could lead to

If it had worked, this could point toward a regenerative treatment for hair loss using a person's own cells.

What could go wrong

The trial was withdrawn before enrolling anyone, so no data exists. Early-phase studies often fail to show benefit or have unexpected side effects.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ANDROGENETIC ALOPECIA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

alopecia androgenetic alopecia disorder of pilosebaceous unit

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Kenneth Williams, DO

    Irvine, California, 92618, United States